$YCBD News

Maxim Group Downgrades cbdMD to Hold

cbdMD Inc (YCBD) (Q3 2026) Earnings Call Highlights: Strategic Pivot and Cost Cuts Aim to ...

cbdMD, Inc. (YCBD) Q3 2026 Earnings Call Transcript

cbdMD Reports 20% Year-over-Year Revenue Growth for the Third Fiscal Quarter of 2026

cbdMD Q3 2026 Earnings Call: Complete Transcript

cbdMD, Inc. to Host Conference Call to Discuss June 30, 2026, Third Quarter Results

cbdMD Applauds Proposed SENATE SPENDING BILL That Would Protect Access to Full-Spectrum CBD and Other Naturally Derived Hemp Products

cbdMD Supports the Bipartisan Lawful Hemp Protection Act to Protect Consumers and Full-Spectrum CBD Access

cbdMD's Oasis Brand Partners with Mexcor to Launch Into South Carolina

cbdMD's Bluebird Botanicals Announces Official Partnership With Denver Audubon to Support Bird Conservation

cbdMD Sets a New Safety Standard for Broad Spectrum CBD With Self-Affirmed GRAS Determination

Oasis Launches Hemp-Derived Mixer

cbdMD Welcomes White House Call for Fair Treatment of Hemp-Derived Products

cbdMD Appoints Wade Brown Chief Marketing Officer

Why cbdMD Inc (YCBD)’s Management is Optimistic After March Quarter Results

cbdMD Inc (YCBD) Q2 2026 Earnings Call Highlights: Strong Sales Growth Amidst Regulatory Challenges

cbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum

cbdMD, Inc. (YCBD) Q2 2026 Earnings Call Transcript

Full Transcript: cbdMD Q2 2026 Earnings Call

cbdMD Q2 EPS $(0.08) Misses $(0.05) Estimate, Sales $5.640M Beat $5.292M Estimate